vs
LXP Industrial Trust（LXP）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
LXP Industrial Trust的季度营收约是RIGEL PHARMACEUTICALS INC的1.2倍（$86.7M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 33.2%，领先350.9%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -14.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 0.3%）
LXP工业信托是一家公开上市的房地产投资信托，专注于持有、运营和投资美国核心市场的优质工业地产，主要涵盖配送中心、物流设施及轻型工业物业，服务电商、第三方物流、先进制造等领域租户，为投资者创造长期稳定收益。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LXP vs RIGL — 直观对比
营收规模更大
LXP
是对方的1.2倍
$69.8M
营收增速更快
RIGL
高出35.2%
-14.0%
净利率更高
RIGL
高出350.9%
33.2%
两年增速更快
RIGL
近两年复合增速
0.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.7M | $69.8M |
| 净利润 | $28.8M | $268.1M |
| 毛利率 | 81.5% | 91.5% |
| 营业利润率 | 34.6% | 33.2% |
| 净利率 | 33.2% | 384.0% |
| 营收同比 | -14.0% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LXPRIGL
| Q4 25 | $86.7M | $69.8M | ||
| Q3 25 | $86.9M | $69.5M | ||
| Q2 25 | $87.7M | $101.7M | ||
| Q1 25 | $88.9M | $53.3M | ||
| Q4 24 | $100.9M | $57.6M | ||
| Q3 24 | $85.6M | $55.3M | ||
| Q2 24 | $85.8M | $36.8M | ||
| Q1 24 | $86.3M | $29.5M |
净利润LXPRIGL
| Q4 25 | $28.8M | $268.1M | ||
| Q3 25 | $36.3M | $27.9M | ||
| Q2 25 | $29.1M | $59.6M | ||
| Q1 25 | $19.0M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $6.3M | $12.4M | ||
| Q2 24 | $5.4M | $-1.0M | ||
| Q1 24 | $-269.0K | $-8.2M |
毛利率LXPRIGL
| Q4 25 | 81.5% | 91.5% | ||
| Q3 25 | 82.3% | 93.2% | ||
| Q2 25 | 81.9% | 95.6% | ||
| Q1 25 | 80.7% | 91.7% | ||
| Q4 24 | 85.3% | 89.9% | ||
| Q3 24 | 82.5% | 85.5% | ||
| Q2 24 | 82.0% | 92.4% | ||
| Q1 24 | 82.4% | 93.1% |
营业利润率LXPRIGL
| Q4 25 | 34.6% | 33.2% | ||
| Q3 25 | 50.4% | 40.9% | ||
| Q2 25 | 33.7% | 60.1% | ||
| Q1 25 | 21.8% | 23.9% | ||
| Q4 24 | — | 28.9% | ||
| Q3 24 | 7.9% | 25.4% | ||
| Q2 24 | 6.9% | 1.2% | ||
| Q1 24 | 1.0% | -23.6% |
净利率LXPRIGL
| Q4 25 | 33.2% | 384.0% | ||
| Q3 25 | 41.7% | 40.2% | ||
| Q2 25 | 33.2% | 58.6% | ||
| Q1 25 | 21.4% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 7.4% | 22.5% | ||
| Q2 24 | 6.3% | -2.8% | ||
| Q1 24 | -0.3% | -27.9% |
每股收益（稀释后）LXPRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.12 | $1.46 | ||
| Q2 25 | $0.09 | $3.28 | ||
| Q1 25 | $0.06 | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | $0.02 | $0.70 | ||
| Q2 24 | $0.01 | $-0.06 | ||
| Q1 24 | $-0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $170.4M | $155.0M |
| 总债务越低越好 | $1.4B | $52.5M |
| 股东权益账面价值 | $2.0B | $391.5M |
| 总资产 | $3.5B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.66× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LXPRIGL
| Q4 25 | $170.4M | $155.0M | ||
| Q3 25 | $229.7M | $137.1M | ||
| Q2 25 | $71.0M | $108.4M | ||
| Q1 25 | $70.9M | $77.1M | ||
| Q4 24 | $101.8M | $77.3M | ||
| Q3 24 | $55.0M | $61.1M | ||
| Q2 24 | $48.7M | $49.1M | ||
| Q1 24 | $293.8M | $49.5M |
总债务LXPRIGL
| Q4 25 | $1.4B | $52.5M | ||
| Q3 25 | $1.5B | $60.0M | ||
| Q2 25 | $1.5B | $60.0M | ||
| Q1 25 | $1.5B | $60.0M | ||
| Q4 24 | $1.6B | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益LXPRIGL
| Q4 25 | $2.0B | $391.5M | ||
| Q3 25 | $2.1B | $117.6M | ||
| Q2 25 | $2.1B | $81.9M | ||
| Q1 25 | $2.1B | $18.6M | ||
| Q4 24 | $2.1B | $3.3M | ||
| Q3 24 | $2.1B | $-14.6M | ||
| Q2 24 | $2.1B | $-29.9M | ||
| Q1 24 | $2.2B | $-31.7M |
总资产LXPRIGL
| Q4 25 | $3.5B | $513.6M | ||
| Q3 25 | $3.7B | $242.5M | ||
| Q2 25 | $3.7B | $206.7M | ||
| Q1 25 | $3.8B | $176.0M | ||
| Q4 24 | $3.8B | $164.0M | ||
| Q3 24 | $3.9B | $139.4M | ||
| Q2 24 | $3.9B | $128.4M | ||
| Q1 24 | $4.2B | $126.5M |
负债/权益比LXPRIGL
| Q4 25 | 0.66× | 0.13× | ||
| Q3 25 | 0.72× | 0.51× | ||
| Q2 25 | 0.72× | 0.73× | ||
| Q1 25 | 0.73× | 3.23× | ||
| Q4 24 | 0.75× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $188.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 6.56× | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流LXPRIGL
| Q4 25 | $188.7M | $22.0M | ||
| Q3 25 | $63.5M | $24.0M | ||
| Q2 25 | $44.3M | $30.5M | ||
| Q1 25 | $39.0M | $-893.0K | ||
| Q4 24 | $211.2M | $14.5M | ||
| Q3 24 | $64.6M | $21.7M | ||
| Q2 24 | $38.5M | $302.0K | ||
| Q1 24 | $38.9M | $-5.0M |
现金转化率LXPRIGL
| Q4 25 | 6.56× | 0.08× | ||
| Q3 25 | 1.75× | 0.86× | ||
| Q2 25 | 1.52× | 0.51× | ||
| Q1 25 | 2.05× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 10.18× | 1.75× | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
